![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, January 02, 2013 11:32:17 PM
It has collaborated with MerckBSE 1.25 % Serono to co-develop a portfolio of biosimilar compounds in oncology, primarily focused on monoclonal antibodies (MAbs). It indicated that this would see the quantitative visibility over the long run.
It launched a prostrate cancer drug, PamorelinO LA, in India. The company has signed an exclusive marketing and sales agreement with Debiopharma Group of Switzerland. Dr Reddy's will import the drug in bulk and supply the same to urologists and oncologists in India.
On the biosimilars front, the company has alliance with the GSK specifically for the Emerging markets. The Biosimilars, which were in pipeline, would be launched in the Indian market (already launched 4 products) and then in the emerging markets. However, it would take a few years to become a significant contribution to the sales.
The company launched the generic version of sildenafil tablets in the US market. It launched the drug following approval by the USFDA for its abbreviated new drug application for sildenafil tablets.
The company has entered into a partnership with the Cellceutix Corporation based in Massachusetts, a clinical stage biopharmaceutical company. The partnership is for the purpose of manufacturing Prurisol, a new drug candidate for treating psoriasis.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
FEATURED Mawson Finland Limited Expands Known Mineralized Zones at Rajapalot: New Lens Intercepts 21.75 m at 5.25 g/t Gold & 515 ppm Cobalt • Sep 4, 2024 9:02 AM
FEATURED Integrated Ventures Acquires 51% Stake In GetTrim.Com (TM), Telemedicine Platform With Focus On Expansion Into Booming GLP-1 Powered Weight Loss Market • Sep 4, 2024 8:45 AM
VAYK Confirms Receiving Revenue from First Airbnb Property with 1.4 Million Annual Revenue Goal • VAYK • Sep 4, 2024 9:34 AM
Avant Technologies Announces Strategic Review Process Intended to Maximize Shareholder Value • AVAI • Sep 4, 2024 8:00 AM
PickleJar Launches National "Get on the Bus" Campaign, Unveils Thompson Square Tour Bus Wrap • PKLE • Sep 4, 2024 7:17 AM
Maybacks Global and Inventel Products To Launch Global 24 Hour Shopping Channel • AHRO • Sep 3, 2024 9:15 AM